Literatur-DB: Phase I study of autologous dendritic cell tumor vaccine in patients with non-small cell lung cancer.
| Titel: | Phase I study of autologous dendritic cell tumor vaccine in patients with non-small cell lung cancer. |
| Kategorien: | Bronchialkarzinom |
| BuchID: | 70 |
| Autor: | Verschiedene |
| ISBN-10(13): | KA |
| Publikationsdatum: | 2010 11 |
| Number of pages: | 0 |
| Sprache: | Nicht spezifiziert |
| Preis: | 0.00 |
| Bewertung: |
|
| Bild: |
zum Original
|
| Beschreibung: |
AbstractBACKGROUND:A dendritic cell vaccine has been developed as a novel strategy for generating antitumor immunity in the treatment of cancer. The purpose of this study was to assess the maximal tolerated dose, safety, and immunologic response of a new dendritic cell vaccine (DC-Vac) into which tumor lysate was loaded by electroporation and pulse in patients with advanced non-small cell lung cancer (NSCLC). Artikel-Nr.: 70(2):188-94 | PubMed-ID: 20223553 | DOI: 10.1016/j.lungcan.2010.02.006 | ISBN: |
Rezensionen
